Academic Credentials
  • Ph.D., Cell and Molecular Biology, University of Cincinnati, 2007
  • B.A., Biology, Wittenberg University, 2000
Licenses & Certifications
  • Diplomate of the American Board of Toxicology (DABT)
Additional Education & Training
  • Post-Doctoral Fellow, EPA Office of Research and Development National Center for Environmental Assessment, Cincinnati, Ohio, 2007-2010
Professional Affiliations
  • Member of Society of Toxicology, Risk Assessment Specialty Section, Women in Toxicology Special Interest Group
  • Interstate Technology and Regulatory Council (ITRC) Workgroup member
  • - Per- and Polyfluoroalkyl substances (2017-2022)
  • - 1,4-Dioxane (2019- 2025)
  • - Microplastics (2022-2023)
  • Water and Health Advisory Council – Council member (2023-present)

Dr. Janet Anderson is the Practice Director and Principal Scientist of Exponent's Health Sciences practice. She is a human health toxicologist and risk assessor with more than 15 years of experience providing toxicology expertise and consultation to federal agencies, municipalities, and private industry. Dr. Anderson is a Diplomate of the American Board of Toxicology and specializes in the synthesis of human health toxicology data into regulatory and legislative policies that govern corporate chemical risk management, environmental risk, product stewardship, and public health protection.

Dr. Anderson is an internationally recognized leader in unregulated and emerging chemicals, such as per- and polyfluoroalkyl substances (PFAS), 1,4-dioxane, and microplastics. She works regularly with legal counsel specializing in risk, compliance, and safety related to chemical and product stewardship in various industries, including national security, energy, aerospace, advanced materials manufacturing, technology, and specialty chemicals. She equips clients with the technical foundation to navigate varied governmental and legal actions across domestic and international jurisdictions. She also has extensive experience developing corporate risk management strategies for emerging and legacy chemicals, as well as providing clients with due diligence support concerning potential liability across the full lifecycle of product manufacturing, use, and disposal, as well as when evaluating mergers and acquisitions. She also conducts site-specific risk assessments, including for CERCLA and numerous state-led cleanup sites. With in-depth knowledge of federal, state, and international guidance and policies pertaining to chemicals and human health, she has developed strategies to mitigate potential human health impacts and address associated business risks for both private and public sector clients.

Dr. Anderson is a skilled communicator; she is often an invited speaker at high-level scientific conferences, regulatory meetings, webinars, and community stakeholder meetings. Dr. Anderson also serves as a testifying expert and supports clients in public and private stakeholder engagement. She excels at translating complex scientific information used to inform risk, regulatory, and public health decisions to different audiences and stakeholders. With a comprehensive background in evaluating emerging and legacy chemicals' toxic properties across divergent state, federal and international regulatory paradigms, she ensures that scientifically informed processes are utilized in decision-making.